Research ArticleSystemic Sclerosis

Understanding the Employment Landscape in People With Systemic Sclerosis

Hila Jazayeri, Monique A.M. Gignac, Zareen Ahmad and Sindhu R. Johnson
The Journal of Rheumatology June 2024, 51 (6) 622-627; DOI: https://doi.org/10.3899/jrheum.2023-0975

REFERENCES

  1. 1.↵
    1. Denton CPP,
    2. Khanna DP.
    Systemic sclerosis. Lancet 2017;390:1685-99.
    OpenUrlCrossRefPubMed
  2. 2.↵
    1. Sandusky SB,
    2. McGuire L,
    3. Smith MT,
    4. Wigley FM,
    5. Haythornthwaite JA.
    Fatigue: an overlooked determinant of physical function in scleroderma. Rheumatology 2009;48:165-9.
    OpenUrlCrossRefPubMed
  3. 3.↵
    1. Mihai C,
    2. Landewé R,
    3. van der Heijde D, et al.
    Digital ulcers predict a worse disease course in patients with systemic sclerosis. Ann Rheum Dis 2016;75:681-6.
    OpenUrlAbstract/FREE Full Text
  4. 4.↵
    1. Elhai M,
    2. Meune C,
    3. Avouac J,
    4. Kahan A,
    5. Allanore Y.
    Trends in mortality in patients with systemic sclerosis over 40 years: a systematic review and meta-analysis of cohort studies. Rheumatology 2012;51:1017-26.
    OpenUrlCrossRefPubMed
  5. 5.↵
    1. Mayes MD,
    2. Lacey JV Jr,
    3. Beebe-Dimmer J, et al.
    Prevalence, incidence, survival, and disease characteristics of systemic sclerosis in a large US population. Arthritis Rheum 2003;48:2246-55.
    OpenUrlCrossRefPubMed
  6. 6.↵
    1. Orlandi M,
    2. Lepri G,
    3. Damiani A, et al.
    One year in review 2020: systemic sclerosis. Clin Exp Rheumatol 2020;38 Suppl 125:3-17.
    OpenUrl
  7. 7.↵
    1. Bergamasco A,
    2. Hartmann N,
    3. Wallace L,
    4. Verpillat P.
    Epidemiology of systemic sclerosis and systemic sclerosis-associated interstitial lung disease. Clin Epidemiol 2019;11:257-73.
    OpenUrlCrossRefPubMed
  8. 8.↵
    1. Bernatsky S,
    2. Joseph L,
    3. Pineau CA,
    4. Belisle P,
    5. Hudson M,
    6. Clarke AE.
    Scleroderma prevalence: demographic variations in a population-based sample. Arthritis Rheum 2009;61:400-4.
    OpenUrlCrossRefPubMed
  9. 9.↵
    1. Lee JJY,
    2. Gignac MAM,
    3. Johnson SR.
    Employment outcomes in systemic sclerosis. Best Pract Res Clin Rheumatol 2021;35:101667.
    OpenUrlPubMed
  10. 10.↵
    1. Mura G,
    2. Bhat KM,
    3. Pisano A,
    4. Licci G,
    5. Carta MG.
    Psychiatric symptoms and quality of life in systemic sclerosis. Clin Pract Epidemiol Ment Health 2012;8:30-5.
    OpenUrl
  11. 11.↵
    1. Richards HL,
    2. Herrick AL,
    3. Griffin K,
    4. Gwilliam PDH,
    5. Loukes J,
    6. Fortune DG.
    Systemic sclerosis: patients’ perceptions of their condition. Arthritis Rheum 2003;49:689-96.
    OpenUrlCrossRefPubMed
  12. 12.↵
    1. Park EH,
    2. Strand V,
    3. Oh YJ,
    4. Song YW,
    5. Lee EB.
    Health-related quality of life in systemic sclerosis compared with other rheumatic diseases: a cross-sectional study. Arthritis Res Ther 2019;21:61.
    OpenUrl
  13. 13.
    1. Hudson M,
    2. Thombs BD,
    3. Steele R, et al.
    Health-related quality of life in systemic sclerosis: a systematic review. Arthritis Rheum 2009;61:1112-20.
    OpenUrlCrossRefPubMed
  14. 14.
    1. Steen VD,
    2. Medsger TA.
    The value of the health assessment questionnaire and special patient-generated scales to demonstrate change in systemic sclerosis patients over time. Arthritis Rheum 1997;40:1984-91.
    OpenUrlCrossRefPubMed
  15. 15.
    1. Hudson M,
    2. Thombs BD,
    3. Steele R, et al.
    Quality of life in patients with systemic sclerosis compared to the general population and patients with other chronic conditions. J Rheumatol 2009;36:768-72.
    OpenUrlAbstract/FREE Full Text
  16. 16.↵
    1. Johnson SR,
    2. Glaman DD,
    3. Schentag CT,
    4. Lee P.
    Quality of life and functional status in systemic sclerosis compared to other rheumatic diseases. J Rheumatol 2006;33:1117-22.
    OpenUrlAbstract/FREE Full Text
  17. 17.↵
    1. Charles C,
    2. Clements P,
    3. Furst DE.
    Systemic sclerosis: hypothesis-driven treatment strategies. Lancet 2006;367:1683-91.
    OpenUrlCrossRefPubMed
  18. 18.↵
    1. Hussein H,
    2. Lee P,
    3. Chau C,
    4. Johnson SR.
    The effect of male sex on survival in systemic sclerosis. J Rheumatol 2014;41:2193-200.
    OpenUrlAbstract/FREE Full Text
  19. 19.↵
    1. Allaire SJ,
    2. Keysor JJ,
    3. Alheresh R.
    Effect of arthritis and other rheumatic conditions on employment. Work 2013;45:417-20.
    OpenUrl
  20. 20.
    1. Hudson M,
    2. Steele R,
    3. Lu Y,
    4. Thombs BD, Canadian Scleroderma Research Group,
    5. Baron M.
    Work disability in systemic sclerosis. J Rheumatol 2009;36:2481-6.
    OpenUrlAbstract/FREE Full Text
  21. 21.↵
    1. Mau W,
    2. Listing J,
    3. Huscher D,
    4. Zeidler H,
    5. Zink A,
    6. Schneider M.
    Employment across chronic inflammatory rheumatic diseases and comparison with the general population. J Rheumatol 2005; 32:721-8.
    OpenUrlAbstract/FREE Full Text
  22. 22.↵
    1. Morrisroe K,
    2. Sudararajan V,
    3. Stevens W, et al.
    Work productivity in systemic sclerosis, its economic burden and association with health-related quality of life. Rheumatology 2018;57:73-83.
    OpenUrl
  23. 23.↵
    1. Singh MK,
    2. Clements PJ,
    3. Furst DE,
    4. Maranian P,
    5. Khanna D.
    Work productivity in scleroderma: analysis from the University of California, Los Angeles scleroderma quality of life study. Arthritis Care Res 2012;64:176-83.
    OpenUrl
  24. 24.↵
    1. Health Canada
    . Arthritis in Canada: an ongoing challenge. 2003. [Internet. Accessed January 31, 2024.] Available from: https://publications.gc.ca/Collection/H39-4-14-2003E.pdf
  25. 25.↵
    1. McCormick N,
    2. Marra CA,
    3. Aviña-Zubieta JA.
    Productivity losses and costs in the less-common systemic autoimmune rheumatic diseases. Curr Rheumatol Rep 2017;19:72.
    OpenUrl
  26. 26.↵
    1. Bernatsky S,
    2. Hudson M,
    3. Panopalis P, et al.
    The cost of systemic sclerosis. Arthritis Rheum 2009;61:119-23.
    OpenUrlCrossRefPubMed
  27. 27.↵
    1. Backman CL.
    Employment and work disability in rheumatoid arthritis. Curr Opin Rheumatol 2004;16:148-52.
    OpenUrlCrossRefPubMed
  28. 28.
    1. Al Dhanhani AM,
    2. Gignac MA,
    3. Su J,
    4. Fortin PR.
    Work disability in systemic lupus erythematosus. Arthritis Rheum 2009;61:378-85.
    OpenUrlCrossRefPubMed
  29. 29.↵
    1. Baker K,
    2. Pope J,
    3. Fortin P, et al.
    Work disability in systemic lupus erythematosus is prevalent and associated with socio-demographic and disease related factors. Lupus 2009;18:1281-8.
    OpenUrlCrossRefPubMed
  30. 30.↵
    1. Ouimet JM,
    2. Pope JE,
    3. Gutmanis I,
    4. Koval J.
    Work disability in scleroderma is greater than in rheumatoid arthritis and is predicted by high HAQ scores. Open Rheumatol J 2008;2:44-52.
    OpenUrlCrossRefPubMed
  31. 31.↵
    1. Sandqvist JL,
    2. Henriksson CM.
    Work functioning: a conceptual framework. Work 2004;23:147-57.
    OpenUrl
  32. 32.↵
    1. Gignac MA,
    2. Cao X.
    ‘Should I tell my employer and coworkers I have arthritis?’ A longitudinal examination of self-disclosure in the work place. Arthritis Rheum 2009;61:1753-61.
    OpenUrlCrossRefPubMed
  33. 33.↵
    1. Gignac MAM,
    2. Cao X,
    3. McAlpine J.
    Availability, need for, and use of work accommodations and benefits: are they related to employment outcomes in people with arthritis? Arthritis Care Res 2015; 67:855-64.
    OpenUrlCrossRefPubMed
  34. 34.↵
    1. Gignac MAM,
    2. Jetha A,
    3. Ginis KAM,
    4. Ibrahim S.
    Does it matter what your reasons are when deciding to disclose (or not disclose) a disability at work? The association of workers’ approach and avoidance goals with perceived positive and negative workplace outcomes. J Occup Rehabil 2021;31:638-51.
    OpenUrl
  35. 35.
    1. Gignac MAM,
    2. Kristman V,
    3. Smith PM, et al.
    Are there differences in workplace accommodation needs, use and unmet needs among older workers with arthritis, diabetes and no chronic conditions? Examining the role of health and work context. Work Aging Retire 2018;4:381-98.
    OpenUrlPubMed
  36. 36.↵
    1. Jetha A,
    2. Gignac MAM,
    3. Ibrahim S,
    4. Martin Ginis KA.
    Disability and sex/gender intersections in unmet workplace support needs: findings from a large Canadian survey of workers. Am J Ind Med 2021;64:149-61.
    OpenUrl
  37. 37.↵
    1. Gignac MA,
    2. Lacaille D,
    3. Beaton DE,
    4. Backman CL,
    5. Cao X,
    6. Badley EM.
    Striking a balance: work-health-personal life conflict in women and men with arthritis and its association with work outcomes. J Occup Rehabil 2014;24:573-84.
    OpenUrlPubMed
  38. 38.↵
    1. Gignac MA,
    2. Badley EM,
    3. Lacaille D,
    4. Cott CC,
    5. Adam P,
    6. Anis AH.
    Managing arthritis and employment: making arthritis-related work changes as a means of adaptation. Arthritis Rheum 2004;51:909-16.
    OpenUrlCrossRefPubMed
  39. 39.↵
    1. Dwyer DJ,
    2. Ganster DC.
    The effects of job demands and control on employee attendance and satisfaction. J Organ Behavior 1991;12:595-608.
    OpenUrl
  40. 40.↵
    1. Bailis DS,
    2. Segall A,
    3. Chipperfield JG.
    Two views of self-rated general health status. Soc Sci Med 2003;56:203-17.
    OpenUrlCrossRefPubMed
  41. 41.↵
    1. Shacham S.
    A shortened version of the Profile of Mood States. J Pers Assess 1983;47:305-6.
    OpenUrlCrossRefPubMed
  42. 42.↵
    1. Reilly MC,
    2. Zbrozek AS,
    3. Dukes EM.
    The validity and reproducibility of a work productivity and activity impairment instrument. Pharmacoeconomics 1993;4:353-65.
    OpenUrlCrossRefPubMed
  43. 43.↵
    1. Gignac MA,
    2. Cao X,
    3. Lacaille D,
    4. Anis AH,
    5. Badley EM.
    Arthritis-related work transitions: a prospective analysis of reported productivity losses, work changes, and leaving the labor force. Arthritis Rheum 2008;59:1805-13.
    OpenUrlCrossRefPubMed
  44. 44.↵
    1. Mattke S,
    2. Balakrishnan A,
    3. Bergamo G,
    4. Newberry SJ.
    A review of methods to measure health-related productivity loss. Am J Manag Care 2007;13:211-7.
    OpenUrlPubMed
  45. 45.↵
    1. Jetha A,
    2. Johnson SR,
    3. Gignac MAM.
    Unmet workplace support needs and lost productivity of workers with systemic sclerosis: a path analysis study. Arthritis Care Res 2021;73:423-31.
    OpenUrl
  46. 46.↵
    1. Lee S,
    2. Lee DK.
    What is the proper way to apply the multiple comparison test? Korean J Anesthesiol 2018;71:353-60.
    OpenUrlCrossRefPubMed
Back to top

In this issue

Print
Download PDF
Article Alerts
Email Article
Citation Tools

 Request Permissions

Bookmark this article

Jump to section

Keywords

EMPLOYMENT
SCLERODERMA
SYSTEMIC SCLEROSIS
WORK

Keywords